Healthequity Inc (NASDAQ:HQY) shares fell 0% during trading on Thursday after an insider sold shares in the company. The company traded as low as $50.68 and last traded at $50.74. 1,268,110 shares changed hands during trading, an increase of 122% from the average session volume of 570,028 shares. The stock had previously closed at $50.74.
Specifically, VP Darcy G. Mott sold 9,500 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $55.19, for a total value of $524,305.00. Following the sale, the vice president now directly owns 102,500 shares in the company, valued at approximately $5,656,975. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jon Kessler sold 59,558 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $55.32, for a total transaction of $3,294,748.56. Following the completion of the sale, the insider now owns 504,558 shares in the company, valued at $27,912,148.56. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 724,137 shares of company stock worth $37,502,418. 29.00% of the stock is owned by company insiders.
A number of equities research analysts have recently weighed in on HQY shares. Zacks Investment Research lowered shares of Healthequity from a “buy” rating to a “hold” rating in a report on Wednesday, November 15th. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a report on Friday, December 22nd. Citigroup started coverage on shares of Healthequity in a report on Thursday, January 4th. They issued a “buy” rating on the stock. Chardan Capital raised their price objective on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a report on Wednesday, December 6th. Finally, Cantor Fitzgerald restated a “buy” rating and issued a $56.00 price objective on shares of Healthequity in a report on Tuesday, December 5th. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $56.67.
The company has a market capitalization of $3,190.00, a PE ratio of 70.96, a P/E/G ratio of 2.16 and a beta of 1.70.
Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.04. The firm had revenue of $56.80 million for the quarter, compared to the consensus estimate of $55.27 million. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The company’s revenue was up 31.0% on a year-over-year basis. During the same period last year, the firm posted $0.10 EPS. equities research analysts anticipate that Healthequity Inc will post 0.73 earnings per share for the current fiscal year.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Grandeur Peak Global Advisors LLC grew its position in shares of Healthequity by 151.4% in the 4th quarter. Grandeur Peak Global Advisors LLC now owns 25,325 shares of the company’s stock valued at $1,182,000 after buying an additional 15,250 shares during the last quarter. Xact Kapitalforvaltning AB purchased a new position in shares of Healthequity in the 4th quarter valued at $220,000. Westover Capital Advisors LLC purchased a new position in shares of Healthequity in the 4th quarter valued at $702,000. MetLife Investment Advisors LLC purchased a new position in shares of Healthequity in the 4th quarter valued at $1,090,000. Finally, Two Sigma Securities LLC purchased a new position in shares of Healthequity in the 4th quarter valued at $208,000. 99.47% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/24/healthequity-hqy-stock-price-down-0-after-insider-selling.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.